Connective tissue diseases
Introduction
Connective tissue diseases (CTDs) are systemic autoimmune disorders characterized by a large spectrum of clinical features and multisystemic involvement. CTDs include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren syndrome (SS), systemic sclerosis (SSc), dermatomyositis (DM) and polymyositis (PM) However, undifferentiated connective tissue disease is observe in some patients who cannot be assigned to a single disease category. overlap syndrom is observe when manifestations from two or more CTDs are identified in the same patient.
(1)
Systemic lupus erythromatosus
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder with complex etiology. Genetics plays an important role in lupus pathogenesis through its influence on clinical and autoantibody phenotype of the disease. The incidence rates of SLE range from approximately 1 to 10 per 100,000 personyears, and prevalence rates generally range from 20 to 70 per 100,000 (3) SLE, like many autoimmune diseases, affects females more frequently than males, at a rate of about 9 to 1 (4)
The X chromosome carries immunological related genes, which can mutate and contribute to the onset of SLE. The Y chromosome has no identified mutations associated with autoimmune disease Childhood-onset systemic lupus erythematosus generally presents between the ages of 3 and 15 and is four time more common in girls The disease appears to be more common in urban than rural areas. Sixty-five per cent of patients with SLE have disease onset between the ages of 16 and 55 years, 20% present before age 16, and 15% after the age of 55
The prevalence of late-onset systemic lupus erythematosus (SLE) diagnosed in patients over the age of 50 years is estimated at 10% to 20%. 
Aetiology
The aetiology of SLE includes both genetic and environmental components with female sex strongly influencing pathogenesis. These factors lead to an irreversible break in immunological tolerance manifested by immune responses against endogenous nuclear antigens.
Genetic factors
Siblings of SLE patients are approximately 30 times more likely to develop SLE compared with individuals without an affected sibling.
For instance Tranducer And Activator Of Transcription 4Signal (STAT4) a genetic risk factor for rheumatoid arthritis and SLE, is associated with severe SLE. One of the key components of these pathways is TNFAIP3, which has been implicated in at least six autoimmune disorders, including SLE 
Epigenetic effects
The most well understood type of epigenetic factor is DNA methylation, which plays a role in a variety of human processes, such as X chromosome inactivation and certain cancers. Previous research has also implicated the importance of DNA methylation in SLE. Differences in the methylation status of genes may explain, at least in part, the discordance observed in some identical twins that are discordant for SLE. Epigenetic mechanisms may represent the missing link between genetic and environmental risk factors 
Environmental factors
Anumber of environmental triggering factors have been associated with SLE, including UV light and cigarette smoking, some of which trigger lupus through epigenetic mechanisms 
Rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune inflammatory disease that affects approximately 1% of the population. Initial symptoms include joint swelling, stiffness, and tenderness, which are all causes of disability. The diagnosis of RA is based on patient history of joint pain and stiffnes
RA affects between 0.5 and 1% of adults in the developed world with between 5 and 50 per 100,000 people newly developing the condition each year
The incidence rate ratio among ever smoking patients was 1.96 after 30 packyears, and 1.034 per year of smoking implying a doubling of risk after 20 years regardless of sex and smoking intensity (18)
Genetic and Environmental Factors
Rheumatoid arthritis involves a complex interplay among genotype, environmental triggers, and chance. Twin studies implicate genetic factors in rheumatoid arthritis, with concordance rates of 15 to 30% among monozygotic twins and 5% among dizygotic twins
The long-established association with the human leukocyte antigen (HLA)-DRB1 locus has been confirmed in patients who are positive for rheumatoid factor or ACPA.
(20)
These findings suggest that some predisposing T-cell repertoire selection, antigen presentation, or alteration in peptide affinity has a role in promoting autoreactive adaptive immune responses. Genetic risk factors for ACPA-negative disease appear to be not less important than those for ACPA-positive disease. However, they are less well established and involve different HLA alleles (e.g., HLA DRB1*03), interferon regulatory factors (e.g., interferon factor 5), and lectin-binding proteins (e.g., C-type lectin domain family 4 member A)
Moreover, smoking and HLA-DRB1 alleles synergistically increase one's risk of having ACPA.
(23)
Several citrullinated self-proteins are recognized in anti-CCP assays, including α-enolase, keratin, fibrinogen, fibronectin, collagen, and vimentin Infectious agents (e.g., Epstein-Barr virus, cytomegalovirus, proteus species, and Escherichia coli) and their products (e.g., heat-shock proteins) have long been linked with rheumatoid arthritis. 
Systemic sclerosis
Systemic sclerosis (SSc) (scleroderma) is a complex autoimmune disease that clinically manifests as progressive fibrosis of the skin and internal organs. Anticentromere antibodies (ACAs), antitopoisomerase antibodies (ATAs), and anti-RNA polymerase III antibodies (ARAs) are three mutually exclusive SScassociated autoantibodies that correlate with distinct clinical subsets characterized by extent of cutaneous involvement and pattern of organ involvement (27) Scleroderma is a chronic sclerosing disease of the connective tissues. Hidebound skin is an important and characteristic feature of this disease
Scleroderma exists in two forms: morphea (circumscribed scleroderma) and generalized/progressive(diffuse scleroderma).
(29)
Systemic sclerosis is a rare disease. Systemic scleroderma has an incidence of 0.3-2.8/100,000/year and a prevalence of 1-15/100,000. The distinct female predominance is seen in the female: male ratio of 3:1 (30)
Type of Systemic Sclerosis Diffuse Scleroderma
Affects the skin as well as the heart, lungs, GI tract, and kidneys.
Limited Scleroderma
Mostly affects the skin of the face, neck and distal elbows and knees and late in the disease causes isolated pulmonary hypertension.
CREST syndrome (Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, Telangiectasias) is associated with limited scleroderma
The diffuse form of systemic sclerosis (DSSc) occurs equally in males and females. The limited form of systemic sclerosis (LSSc) has a strong female predominance, with a female-to-male ratio of 10:1. 
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Systemic sclerosis usually appears in women aged 30-40 years, and it occurs in slightly oldermen.Pulmonary hypertension leads to 12% of systemic sclerosis-related deaths.
Lung fibrosis and heart changes are responsible for 9% of systemic sclerosisrelated deaths. Genome-wide association studies GWAS identifiedthat IRF8 is specifically associated with lcSSc. The same study also demonstrated that HLA-DQB1 is associated with anti-centromere autoantibodies (ACA) positivity,whereas HLA-DPA1/B1 was associated with antitopoisomerase autoantibodies (ATA) positivity. Less discriminating was NOTCH4, which was associated with the presence of both ACA and ATA
(36)
GWAS show that T cell signalling and interferon signalling pathways are involved in SSc susceptibility, and reveal roles in apoptosis, DNA or RNA degradation and autophagy 
Autoantibodies
To date a majority of patients with PM and DM has at least one myositis specific antibody (MSA) if sensitive techniques to identify autoantibodies are utilized. Other autoantibodies can also be found, so-called myositis-associated autoantibodies (MAAs), which may also be present in other autoimmune diseases such as SLE and SS. The most frequently present MAAs in PM and DM are anti-SSA or anti Ro-52 and anti-PMScl The female-to-male ratio of Sjögren syndrome is 9:1. Sjögren syndrome can affect individuals of any age but is most common in elderly people. Onset typically occurs in the fourth to fifth decade of life One of the consequences of the stimulation of innate immunity is the activation of nuclear factor κB (NFκB), which can occur in a number of different cell types. In salivary gland epithelial cells from patients with pSS, hyperactivation of NFκB has been associated with decreased expression of one of the regulators of NFκB activation, A20 (also known as TNF α-induced protein 3 [TNFAIP3])
Furthermore, the first GWAS in pSS identified an association between this disease and a gene (TNIP1) encoding TNFAIP3-interacting protein 1, a protein that interacts with A20 and is involved in the regulation of NFκB activation. "Childhood-onset systemic lupus erythematosus: an update.". Current opinion in rheumatology 27 (5): 483-9 7-Bertsias GK, Salmon JE and Boumpas DT. 
